| BIAUX | FTHFX | BIAUX / FTHFX | |
| Total Expense Ratio | 1.11 | 0.64 | 173% |
| Annual Report Gross Expense Ratio | 1.11 | 0.64 | 173% |
| Fund Existence | 18 years | 15 years | - |
| Gain YTD | 20.965 | 14.958 | 140% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.24B | 12.1B | 10% |
| Annual Yield % from dividends | 0.49 | 0.57 | 87% |
| Returns for 1 year | 15.97 | 25.81 | 62% |
| Returns for 3 years | 18.48 | 57.42 | 32% |
| Returns for 5 years | 11.82 | 61.82 | 19% |
| Returns for 10 years | 47.72 | 246.73 | 19% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTDX | 178.26 | 4.49 | +2.58% |
| Franklin Biotechnology Discovery C | |||
| DGLYX | 17.39 | 0.14 | +0.81% |
| BNY Mellon Global Stock - Y | |||
| RGBGX | 42.37 | 0.21 | +0.50% |
| American Funds Global Balanced R6 | |||
| INDZX | 20.84 | 0.08 | +0.39% |
| Columbia Intrinsic Value A | |||
| SBHEX | 14.17 | -0.28 | -1.94% |
| Segall Bryant & Hamill Em Mkts Retl | |||